Polycystic ovary syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{ADG}} | {{CMG}}; {{AE}} {{ADG}} | ||
==Overview== | ==Overview== | ||
Secondary preventive measures for PCOS include lifestyle modifications and use of [[metformin]] to prevent [[Diabetes mellitus|diabetes]] and [[Atherosclerosis|atherosclerosis.]] | Secondary preventive measures for polycystic ovary syndrome (PCOS) include lifestyle modifications and use of [[metformin]] to prevent [[Diabetes mellitus|diabetes]] and [[Atherosclerosis|atherosclerosis.]] | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Latest revision as of 18:49, 18 October 2017
|
Polycystic ovary syndrome Microchapters |
|
Differentiating Polycystic ovary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic ovary syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Polycystic ovary syndrome secondary prevention |
|
Risk calculators and risk factors for Polycystic ovary syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Secondary preventive measures for polycystic ovary syndrome (PCOS) include lifestyle modifications and use of metformin to prevent diabetes and atherosclerosis.
Secondary Prevention
Secondary preventive measures for PCOS include:[1]
- Weight loss and metformin may prevent diabetes and atherosclerosis.
- Lifestyle modification, including increased physical activity and healthy diet resulting in weight loss, is also likely to prevent diabetes in PCOS.
References
- ↑ Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO (2016). "Polycystic ovary syndrome". Nat Rev Dis Primers. 2: 16057. doi:10.1038/nrdp.2016.57. PMID 27510637.